본문 바로가기
KERD
논문KCI 등재

Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura

이광수|신혜은|김영인|김중석|박정욱
대한신경과학회 (Korean Neurological Association)|2007.03|Journal of Clinical Neurology|제3권 제1호|pp. 24-30

1

조회

0

다운로드

0

인용

0

참고문헌

초록

Abstract

Background: Recent genetic association studies have investigated the possible genetic role of the dopaminergic system in migraine. Catechol-O-methyltransferase (COMT) is an enzyme that plays a crucial role in the metabolism of dopamine and its genetic polymorphism is associated with three- to fourfold variation of enzymatic activity. Objectives: The objective of this study was to elucidate the role of the COMT polymorphism in the genetic susceptibility to migraine and its phenotypic expression in patients with migraine without aura (MWOA). Methods: Ninety-seven patients with MWOA and 94 healthy volunteers were included in the study. After amplifying COMT genes by the polymerase chain reaction, we assessed their genotype frequencies and allele distributions by based on restriction fragment length polymorphisms. We classified all MWOA patients into two groups according to their COMT genotype: with the L allele (N = 43), and without this allele (N = 54). Results: The genotype frequency and allele distribution of the COMT polymorphism did not differ between MWOA patients and the control group. During migraine attacks, MWOA patients with the L allele showed a higher pain intensity of headache (P = 0.001) and a higher incidence of the accompanying nausea/vomiting (94% vs 75%; P = 0.026) compared with MWOA patients without the L allele. Conclusions: Although the COMT polymorphism does not appear to be involved in predisposition to the development of MWOA, this genetic factor could be involved in the phenotypic expression of MWOA.

참고문헌 (41)

  1. "Sicuteri F. Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache 1980", pp.99~102
  2. Guell A, "Bes A. Clinical value of a dopaminergic agonist administration in migraine patients. Headache 1983"
  3. David J, "Rascol A. Does the piribedil test permit predicting the efficacy of domperidone in the treatment of migraine? Headache 1985", pp.332~333
  4. Bes A, "Geraud G. Pharmacological exploration of dopamine hypersensitivity in migraine patients. Int J Clin Pharmacol Res 1986"
  5. Welch KMA, "Brown E. Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 1990", pp.317~329
  6. Fisher H, "A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series", 13, pp.119~122 (1995)
  7. Emilien G, "Cragg S. Dopamine receptors-physiological understanding to therapeutic intervention potential", 84, pp.133~156 (1999)
  8. Mascia A, "Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data", 18, pp.174~182 (1998)
  9. Cerbo R, "Dopamine hypersensitivity in migraine: role of the apomorphine test", 20, pp.36~41 (1997)
  10. Sicuteri F. Dopamine, "the second putative protagonist in headache. Headache 1977", pp.129~131
  11. Honkasalo ML, "Migraine and concomitant symptoms among 8167 adult twin pairs", 35, pp.70~78 (1995)
  12. Larsson B, "Genetic influence in headaches: a Swedish twin study", 35, pp.513~519 (1995)
  13. Russell MB, "Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia 1993", pp.245~248
  14. Lachman HM, "Association of codon 108", 158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome, 1996, pp.67, 468~472
  15. Strous RD, "Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia", 41, pp.493~495 (1997)
  16. Syvanen AC, "Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S- COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland", 7, pp.65~71 (1997)
  17. Daniels JK, "No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity", 153, pp.268~270 (1996)
  18. Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders", 6, pp.243~250 (1996)
  19. Papolos DF, "Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele", 3, pp.346~349 (1998)
  20. Ermin Erdal M, "Significance of the catechol-O-methyltransferase gene polymorphism in migraine", 94, pp.193~196 (2001)
  21. Headache classification subcommittee of the international headache society, "The international classification of headache disorders. 2nd Edn", (Suppl), pp.1~160 (2004), Headache classification subcommittee of the international headache society
  22. Peroutka SJ, "Dopamine and migraine", 49, pp.650~656 (1997)
  23. Peroutka SJ, "Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles", 49, pp.201~206 (1997)
  24. Del Zompo M, "Association between dopamine receptor genes and migraine without aura in a Sardinian sample", 51, pp.781~786 (1998)
  25. Dichgans M, "The D2 receptor NcoI allele: absence of allelic association with migraine with aura", 51, pp.928~ (1998)
  26. Lea RA, "Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine", 3, pp.35~40 (2000)
  27. Shepherd AG, "Dopamine receptor genes and migraine with and without aura: an association study", 42, pp.346~351 (2002)
  28. Mochi M, "A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes", 23, pp.301~305 (2003)
  29. Vladic A, "Jernej B. Monoamine oxidases A and B gene polymorphisms in migraine patients. J Neurol Sci 2005", pp.149~153
  30. Lesch KP, "Sommer C. Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine. J Neural Transm 2004", pp.603~609
  31. Lachman H, "et al. Association between the functional variant of the catechol-O-methyltransferase", vka j, pp.286~289
  32. Karvonen MK, "et al. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 2000", pp.135~159
  33. Lachman H, "et al. Lack of association between the functional variant of the catechol-O-methyltransferase gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Gene. 2000", vka j, pp.348~352
  34. Haruo Shibuya T, "Arinami T. Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism. Psychiatr Gene 1999 Katayama Y. Association between catechol-O-methyltransferase polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics. Addict Biol 2001", pp.233~238
  35. "Dong WK. The role of the basal ganglia in nociception and pain. Pain 1995", pp.3~38
  36. "Paalzow GH. L-dopa induces opposing effects on pain in intact rats SCH 23390 or alpha-methyl-DL- p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Ther 1992", pp.470~479
  37. Silberstein SD, "Alam AS. Acute migraine treatment with droperidol", pp.315~321
  38. Wang SJ, "Young WB. Droperidol treatment of status migrainosus and refractory migraine. Headache 1997", pp.377~382
  39. Hyde TM, "Murray AM. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 1996", pp.224~232
  40. Kohli JD, "Goldberg LI. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol 1983", pp.137~141
  41. Pietrini U, "myth and facts about basilar artery migraine. In", pp.147~160 (1985)

관련 논문AI추천

전조성 편두통과 호모시스테인 및 MTHFR C677T 유전자 다형성의 상관 관계김옥준, 김현조, 서정호, 이일형, 최병옥대한신경과학회 · 대한신경과학회지2004 · 제22권 제3호Migraine Susceptibility Genes in Han Chinese of Fujian ProvinceGen-bin Huang, Jing Yang, Long-teng Yao, Luo-yuan Cao, Qi-fang Lin, Xian-guo Fu, Yong-tong Xin, Zi-chun Chen대한신경과학회 · Journal of Clinical Neurology2017 · 제13권 제1호Association between the G252A Tumor Necrosis Factor-β Gene Polymorphism and Medication-Overuse HeadacheHideyo Kasai, Hirotaka Katoh, Masakazu Ishii, Mitsuru Kawamura, Shunichi Shimizu, Tomomi Onaya, Yuji Kiuchi대한신경과학회 · Journal of Clinical Neurology2012 · 제8권 제4호Genome-Wide Architecture of East Asian Patients With Migraine: A Genome-Wide Association Study Based on Familial History주민경, Joonho Kim대한신경과학회 · Journal of Clinical Neurology2024 · 제20권 제4호Association of Polymorphisms within the Serotonin Receptor Genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and Migraine Susceptibility in a Turkish PopulationAbdullah Çim, Beyhan Cengiz, Ertuğrul Uzar, Hasan H. Özdemir, M. Akif Camkurt, M. Ufuk Aluclu, Salih Coşkun, Yavuz Yücel대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제3호Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs강나미, 김만호, 김병건, 김성찬, 김성훈, 이순태, 임우석대한신경과학회 · Journal of Clinical Neurology2007 · 제3권 제3호

이 간행물의 다른 논문 (11건)

Ultrasound Enhanced Thrombolysis: Applications in Acute Cerebral IschemiaAndrei V, Georgios Tsivgoulis, Alexandrovpp. 1-8Cognitive Dysfunction in 16 Patients with Carotid Stenosis: Detailed Neuropsychological Findings이보람, 김상윤, 김정은, 유인규, 이병희, 전종은, 이수주pp. 9-17Decreased Vasomotor Reactivity in Alzheimer’s Disease이용석, 이순태, 정근화pp. 18-23Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients이호원, 권순학, 박성파, 이다인, 서정규, 황양하, 서종근, 정두교pp. 31-37Anticipation and Phenotypic Heterogeneity in Korean Familial Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Gene Mutation김우준, 이권행, 김중석, 김진모, 권영주, 이광수pp. 38-44
원문 보기